About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Pancreatic Cancer Clinical Trials in Philadelphia | 250 Studies

Clinical Trials Pancreatic CancerPhiladelphia

Pancreatic Cancer Clinical Trials in Philadelphia

Find 250 clinical trials for pancreatic cancer near Philadelphia, Pennsylvania. Connect with research centers in your area.

All Pancreatic Cancer trials nationwide All trials in Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 81-100 of 250 trials

CompletedPediatric Longitudinal Cohort Study of Chronic PancreatitisThe investigators will enroll a total of 628 patients under 18 years of age with ARP or CP.NCT03672422·Beverly Hills, California and 21 others CompletedA Phase 2 Study of MM-141 Plus Nab-paclitaxel and Gemcitabine in Front-line Metastatic Pancreatic CancerThe purpose of this study is to determine whether the combination of MM-141 plus nab-paclitaxel and gemcitabine is more effective than nab-paclitaxel and gemcitabine alone based…NCT02399137·Gilbert, Arizona and 65 others

Pancreatic Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix San Antonio

Data from ClinicalTrials.govTerms

CompletedNT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid TumorsThe main purposes of Phase 1b of this study are to determine the following in participants with advanced solid tumors: * Safety and tolerability of NT-I7 in combination with…NCT04332653·Tampa, Florida and 7 others

TerminatedStudy of Safety and Tolerability of Intravenous CRS-207 in Adults With Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates for Standard TreatmentThis clinical trial will evaluate the safety and tolerability of CRS 207 an investigational product that is a weakened form (attenuated) of Listeria monocytogenes, a type of…NCT00585845·Baltimore, Maryland and 3 others

Active not recruitingStudy of LP-184 in Patients With Advanced Solid TumorsThe primary objective of this study is to evaluate the safety, tolerability, MTD and RP2D of LP-184 in patients with advanced solid tumors who have relapsed from or are refractory…NCT05933265·Springdale, Arkansas and 6 others

Active not recruitingTargeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)This phase II MATCH screening and multi-sub-trial studies how well treatment that is directed by genetic testing works in patients with solid tumors, lymphomas, or multiple…NCT02465060·Birmingham, Alabama and 1409 others

RecruitingNutrition Intervention for Pancreatic CancerPatients with pancreatic cancer (pancreatic ductal adenocarcinoma (PDAC) and pancreatic neuroendocrine tumor (NET)) commonly experience fat malabsorption due to exocrine…NCT07554560·Philadelphia, Pennsylvania and 1 other

CompletedAutologous Redirected RNA Meso CAR T Cells for Pancreatic CancerThis is a Phase I safety and feasibility study. Subjects will be enrolled serially.NCT01897415·Philadelphia, Pennsylvania

CompletedDNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study)The primary objective of this study, DELFI-L101, is to train and test classifiers for lung cancer detection using the DELFI assay and other biomarker and clinical features.NCT04825834·Homewood, Alabama and 56 others

RecruitingComparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated BiomarkersThe purpose of this study is to compare two approaches for monitoring pancreatic cysts as well as to identify associated biomarkers.NCT04239573·Birmingham, Alabama and 428 others

CompletedSafety Study of Itacitinib (INCB039110) in Combination With Gemcitabine and Nab-Paclitaxel in Subjects With Advanced Solid TumorsTest the hypothesis that itacitinib (INCB039110) can be administered safely in combination with gemcitabine and nab-paclitaxel in subjects with advanced or metastatic cancer.NCT01858883·Scottsdale, Arizona and 7 others

CompletedA Study of a Personalized Cancer Vaccine Targeting Shared NeoantigensThe purpose of this study is to evaluate the dose, safety, immunogenicity and early clinical activity of GRT-C903 and GRT-R904, a neoantigen-based therapeutic cancer vaccine, in…NCT03953235·Phoenix, Arizona and 11 others

Active not recruitingPHL Treatment in Pancreatic CancerThis proposal will investigate the effect of paricalcitol, hydroxychloroquine, and losartan (PHL) combination of 3 stroma-modifying drugs on pancreatic adenocarcinoma and its…NCT05365893·Philadelphia, Pennsylvania

RecruitingCT-95 in Advanced Cancers Associated With Mesothelin ExpressionThis is a Phase 1a/1b, first-in-human (FIH), open-label, multi-center dose escalation and expansion study of the safety, pharmacokinetics (PK), pharmacodynamics, and antitumor…NCT06756035·Denver, Colorado and 8 others

CompletedA Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Participants With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)This was an open-label, nonrandomized, Phase 1/2 study designed to determine the safety, tolerability, and efficacy of epacadostat when given in combination with pembrolizumab and…NCT03085914·Phoenix, Arizona and 15 others

CompletedQUILT-2.019: A Study of AMG 655 or AMG 479 in Combination With Gemcitabine for Treatment of Metastatic Pancreatic CancerThis is a multi-center, 2-part study of AMG 655, AMG 479 or AMG 655-placebo plus gemcitabine as first-line treatment of subjects with metastatic pancreatic cancer.NCT00630552·Alhambra, California and 43 others

TerminatedA Study to Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR GenesA Phase 2, open-label, single-arm trial to evaluate the response of rucaparib in participants with various solid tumors and with deleterious mutations in Homologous Recombination…NCT04171700·Los Angeles, California and 18 others

CompletedA Study of SY 5609, a Selective CDK7 Inhibitor, in Advanced Solid TumorsThe study consists of 2 parts.NCT04247126·Gilbert, Arizona and 15 others

RecruitingA Study of LY4337713 in Participants With FAP-Positive Solid TumorsThis is a study of LY4337713 in participants with certain types of cancer that is advanced or has spread.NCT07213791·Newport Beach, California and 29 others

CompletedRadiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic CancerRATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells.NCT00003591·Birmingham, Alabama and 233 others

PreviousPage 5 of 13Next

Other Conditions in Philadelphia

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia